Markets
Alerts
F&O
MF
Reports
Screeners
Subscribe
Superstars
Portfolio
Watchlist
Insider Trades
Results
Data Downloader
Events Calendar
What's New
Explore
FAQs
All Features
Widgets
More
Search stocks
IND
USA
IND
IND
×
Close
IND
USA
Stocks
Futures & Options
Mutual Funds
News
Fundamentals
Reports
Corporate Actions
Alerts
Shareholding
Overview
Buy Sell Zone
Financials
News
All
News
Earnings Calls
Corporate Announcements
Research Reports
Reports
Technicals
Technicals
Share Price History
Delivery
Shareholding
Shareholding
Monthly MF Holdings
Bulk Block Deals
Insider Trading & SAST
Deals
Bulk Block Deals
Insider Trading & SAST
Corporate Actions
All
Dividend
Bonus
Split
Rights
Board Meetings
Alerts
About
Granules India Ltd.
NSE: GRANULES
|
BSE: 532482
|
ISIN: INE101D01020
|
Industry: Pharmaceuticals
US FDA Approval
52 week high
|
Strong Performer, Getting Expensive
612.4000
-2.40
(
-0.39
%)
NSE
Dec 24, 2025
15:31 PM
New 52W High today
Volume:
3.3M
High volume today
Share on Facebook
Tweet
Share on LinkedIn
Share via Whatsapp
Granules India Ltd.
09 Aug 2023
US FDA Approval
52 week high
612.40
-0.39%
IT issue adversely impacted earnings
Buy:
Granules India Ltd.
by
Motilal Oswal
Target: 370
Target
Motilal Oswal
Mutual Funds have decreased holdings from 12.24% to 6.54% in Sep 2025 qtr
More from Granules India Ltd.
Recommended
Nifty 50 in 2025: A market hit by policy and trade pressures
The Baseline |
24 Dec 2025, 06:56PM
Market closes lower amid profit booking and foreign investor outflows
Trendlyne Marketwatch |
24 Dec 2025, 04:02PM
Granules: Will the record-breaking numbers sustain for this API pharmaceutical company?
|
30 Oct 2020